Neuropacs Parkinsonian Syndromes

by Neuropacs  · Based in United States → — Precision AI Improving Neurodegenerative Clinical Outcomes
Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Neuropacs Parkinsonian Syndromes(by Neuropacs) is an AI-powered, prescription-only software application designed to assist in differentiating Parkinson’s disease (PD) from atypical parkinsonian syndromes, specifically multiple system atrophy Parkinsonian variant (MSAp) and progressive supranuclear palsy (PSP).

The software is intended for use by neurologists and neuroradiologistsevaluating patients aged 40 years and older who present with parkinsonian symptoms. It is designed as an adjunctive diagnostic aid to provide supplemental information alongside standard neurological assessments, rather than as a standalone diagnostic tool.

Clinical Workflow Integration:

  • The platform operates via a secure, cloud-based workflow.
  • It utilizes standard, non-invasive diffusion MRI sequences acquired on 3 Tesla clinical MRI systems from major manufacturers, including Siemens, GE Healthcare, and Philips.
  • The system processes the imaging data using a validated free-water imaging (FWI) model and machine learning algorithms to analyze degenerative brain patterns.
  • It automatically generates a classification report detailing the degenerative patterns associated with MSAp and PSP to support clinical decision-making and patient stratification.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-driven diagnostics trained on harmonized multi-site data
  • Exclusive, patented Free-Water Imaging (FWI) technology
  • Up to 96% accuracy in distinguishing PD from MSAp and PSP
  • Quantitative disease insights (measures severity, rate, and state of degeneration)
  • Next-level sensitivity for detecting subtle microstructural changes
  • Cloud-based workflow for seamless integration
  • Supports clinical decision-making and clinical trial outcomes
  • Analyzes patient-specific diffusion MRI data
  • Compatible with standard diffusion MRI sequences on 3T MRI systems (Siemens, GE Healthcare, Philips)
  • Generates classification reports for Parkinsonian syndromes

Use Cases

  • Differentiating Parkinson's disease from atypical parkinsonian syndromes (MSAp, PSP)
  • Improving diagnostic accuracy in neurodegenerative diseases
  • Patient stratification for neurodegenerative clinical trials
  • Measuring quantitative progression markers for efficacy assessment in trials
  • Optimizing clinical endpoint achievement in trials
  • Supporting neuroradiologists and neurologists in clinical assessment

What Physicians Need to Know

Evidence Base
The product is the result of decades of research led by world-class clinicians and neuroscientists from the University of Florida and UF Health Norman Fixel Institute for Neurological Diseases. It leverages AI-driven diagnostics trained on harmonized multi-site data and Free-Water Imaging (FWI).
Clinical Validation Studies
Validated across thousands of MRI scans and multiple clinical trials. Peer-reviewed results are available, and 21 sites were involved in the most recent clinical trial. Over 1000 unique datasets have been analyzed.
Differential Diagnosis Support
Unmatched Accuracy: Up to 96% precision in distinguishing PD from MSAp and PSP. It provides precise diagnostic insights and patient stratification tools for neurodegenerative clinical trials.
Clinical Workflow Integration
Delivered via secure cloud-based workflow, it offers seamless integration into existing imaging workflows.
Physician Tip

Neuropacs offers high precision in distinguishing Parkinsonian Syndromes, with up to 96% accuracy in differentiating PD from MSAp and PSP. Its AI-powered, imaging-enabled software provides quantitative disease insights, measuring severity, rate, and state of degeneration. The platform detects subtle microstructural changes beyond what volumetric imaging sees, which can be crucial for early disease detection and monitoring. It is backed by extensive research and validated across numerous MRI scans and clinical trials, providing academic rigor and real-world applicability.

The platform is delivered via a secure cloud-based workflow and is designed for seamless integration into existing imaging workflows.

Details

Category Clinical Decision Support & Reference, Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-based
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Neuropacs Parkinsonian Syndromes

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Neuropacs Parkinsonian Syndromes.

View all on YouTube

Frequently Asked Questions

Neuropacs provides actionable insights and integrates into existing imaging workflows to support clinical decision-making.
It is built for neurodegenerative diseases to detect disease, quantify neurodegeneration, and analyze clinical diagnostics.
It leverages AI-driven diagnostics trained on harmonized multi-site data and uses Free-Water Imaging (FWI), a diffusion MRI method.
The comprehensive toolset is delivered via a secure cloud-based workflow.
It has up to 96% precision in distinguishing Parkinson's Disease (PD) from Multiple System Atrophy (MSAp) and Progressive Supranuclear Palsy (PSP).

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-09 | First Added: 2026-07-09
AI Tool Finder
AI-powered search. Results may not be comprehensive.